Full text is available at the source.
Abstract
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) may influence the surgery-free interval in idiopathic subglottic stenosis (iSGS).
- GLP-1RAs are known for their systemic anti-inflammatory effects and weight loss benefits.
- The specific impact of GLP-1RAs on iSGS has not been previously studied.
- This evaluation focuses on the potential relationship between GLP-1RAs and the surgery-free interval in patients with iSGS.
Simplified